Page last updated: 2024-08-17
tributyrin and Neuroblastoma
tributyrin has been researched along with Neuroblastoma in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bianucci, F; Camerin, C; Ferreri, AM; Fronza, R; Guerra, F; Pession, A; Purgato, S; Rocchi, P; Tonelli, R | 1 |
Other Studies
1 other study(ies) available for tributyrin and Neuroblastoma
Article | Year |
---|---|
p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Topics: Acetylation; Acetylcholinesterase; Butyrates; Carrier Proteins; Cell Cycle Proteins; Cell Differentiation; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Enzyme Inhibitors; Fatty Acids; Gene Expression Regulation; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Intracellular Signaling Peptides and Proteins; Neurites; Neuroblastoma; Triglycerides; Tumor Cells, Cultured; Valproic Acid | 2005 |